Debunking Common Myths About Psychiatric Medications in Congregate Care

Pharmacy Times interviews Allison Burns, PharmD, RPh, the CEO of End Mass Overdose (EMO) Health to discuss common myths and misconceptions surrounding antidepressants, antipsychotics, and medications for addiction treatment in congregate care settings.

Burns discussed the persistent stigma and misconceptions surrounding mental health conditions and substance use disorders in congregate care settings, emphasizing how these beliefs can create barriers for individuals seeking care and support. According to Burns, many of these settings serve patients for extended periods, often longer than 30 days, which can lead staff and administrators to have concerns about caring for individuals with mental health needs.

One of the most common misconceptions, Burns explained, is the belief that patients taking medications for mental health conditions are inherently unstable, unpredictable, or too acutely ill to safely reside in congregate care environments. Burns noted that these assumptions often stem from fear rather than evidence and can result in unnecessary exclusion or hesitation when admitting individuals with psychiatric conditions.

Burns also highlighted concerns related to controlled substances, particularly medications such as benzodiazepines that may be prescribed for conditions like panic disorder or anxiety. In some cases, staff members may worry about the potential for medication misuse, especially among individuals with a history of substance use disorder. There may also be fears that patients could become disruptive, harm themselves, or pose a risk to others if medications are delayed or unavailable. However, Burns stressed that these concerns are often rooted in stigma rather than the realities of patient care.

According to Burns, many of these challenges can be traced to training gaps among the congregate care workforce. Not all staff members receive education on recognizing mental health crises, responding appropriately to behavioral health concerns, or using de-escalation techniques. As a result, uncertainty can contribute to fear and misunderstanding.

Burns emphasized that individuals living with mental health disorders are no different from other patients in their ability to safely participate in congregate care settings. Increased education, training, and awareness, Burns noted, could help reduce stigma, improve confidence among care teams, and support more inclusive care environments for individuals with mental health and substance use-related conditions.